Report

  • Home |
  • Reports |
  • Global Nuclear Medicine Market by Product Type (Diagnostic, Therapeutic) and by End-Users/Applicatio....
src

Global Nuclear Medicine Market by Product Type (Diagnostic, Therapeutic) and by End-Users/Application (Oncology, Cardiology, Neurology, Thyroid , and Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2018 – 2032

 Report Code
 Category
 Published Date
 Pages
 Format
iSay-2216
Life Sciences
10 December 2023
205
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

Global Nuclear Medicine Market

ISay Research has published a new report titled Nuclear Medicine Market share, Forecast data, In-Depth Analysis, and Forecast, 2023-2032”. According to the report, Global Nuclear Medicine Market in 2022 stood at USD 8.7 billion and is expected to reach USD 25.15 billion by 2032 growing at a CAGR of 9.5% from 2023 to 2032.

Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. These are used in diagnosing and treating certain illnesses. It is specially designed cameras allow doctors to track the path of these radioactive tracers. It helps physicians identify, diagnose, and treat certain conditions by using small amounts of radioactive material. Nuclear medicine can be used in both a diagnostic and therapeutic capacity.

Nuclear Medicine Market: Key Players

The research study includes profiles of leading companies operating in the global Nuclear Medicine market. Key players profiled in the report include: Mallinckrodt plc, General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., IBA Group, Bracco Imaging, NTP Radioisotopes Soc, Ltd., Siemens Healthcare and others.

Drivers for the Global Nuclear Medicine Market:

Growing prevalence of cancer and cardiac disorders, increasing prevalence of cardiovascular diseases, increasing adaptation of radiopharmaceuticals are the major driving factors for the global nuclear medicine market.

Opportunities for the Global Nuclear Medicine Market:

Similarly, government initiatives and funding for the development of new techniques are anticipated, government funding, and company initiatives creates the huge market opportunity for the global nuclear medicine market in forecast period.

Restrains for the Global Nuclear Medicine Market:
But, some factors such as significantly shorter half-life of radiopharmaceuticals, substantially high cost of these specific medicines, and shutting down of several nuclear reactors are hamper the growth of the global nuclear medicine market.

Region Wise, Global Nuclear Medicine Market Analysis:

Report covers the region wise analysis; global nuclear medicine can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America leads the global nuclear medicine share due to high investments in R&D and support of government towards the use of medical isotopes, also increasing development of novel technologies for radioisotope production. North America region is followed by Europe and Asia Pacific.

Covid-19: Impact and Recovery Analysis for Global Nuclear Medicine Market:

The world is greatly affected by the uncertain raise of the covid-19 Pandemic among the population. The Corona virus outbreak has disrupted & disturbed every sector of business as well as human activity. In most parts of the world there has been a complete restriction set by governments regarding various activities and in turn this is greatly affecting the financial stability of industries like: nuclear medicine market globally. Nuclear medicine is a diagnostic and therapeutic procedures assistance of patients with diagnosed or suspected COVID-19, and prevention of COVID-19 spreading in the departments. Both diagnostic and therapeutic nuclear medicine procedures declined precipitously with countries worldwide being affected by the pandemic to a similar degree.

Global Nuclear Medicine Market: Product analysis
  • Diagnostic
  • Therapeutic
On the basis of type, diagnostic accounted for largest share of total revenue generated. Because, low cost and wide usage in different applications. Furthermore, digital SPECT scanners are being introduced in the market for nuclear medicine by key players to improve diagnosis also, used for high-energy waves to produce 3D image, whole body scan for high accuracy, and ability to diagnose chronic diseases.

Global Nuclear Medicine Market: Application analysis
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Others
The demand of Global Nuclear Medicine Market is highest from cardiology, due to the low cost of techniques and high adoption rate, also provides the solution to deliver improved workflow for cardiac imaging at a lower cost.

Global Nuclear Medicine Market: Region analysis
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • France
  • Germany
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Rest of L.A.
  • Middle East and Africa
  • Turkey
  • GCC
  • UAE
  • South Africa
  • Rest of Middle East
Snapshot:
 
Attributes Details
Market Size in 2023 USD 8.7 Billion
Market Forecast in 2032 USD 25.15 Billion
Compound Annual Growth Rate (CAGR) 9.5 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Product Type, By Application, By Region
By Product Type
  • Diagnostic
  • Therapeutic
By Application
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Others
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2018 - 2022
Forecast Year 2023 - 2032

Pivotal Fundamentals of the Global Nuclear Medicine Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each nuclear medicine market player.
  • Region-wise and country-wise breakdown of the nuclear medicine market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global nuclear medicine market.
  • Year-on-year growth of the global nuclear medicine market in terms of value and volume.
Conclusion:

At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish nuclear medicine market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Nuclear Medicine Market Overview
            1.1 Product Overview and Scope of Nuclear Medicine

Chapter 2 Impact of COVID 19
            2.1 Impact on Construction Industry
            2.2 Impact on Nuclear Medicine market
            2.3 Consumer Buying Behavior based on Nuclear Medicine Market
            2.4 Recovery and forecast Analysis based on Nuclear Medicine Market

Chapter 3 Executive Summary  
            3.1 Drivers for Nuclear Medicine Market: 
            3.2 Restrain for Nuclear Medicine Market:
            3.3 Opportunity for Nuclear Medicine Market: 
            3.4 Global Nuclear Medicine market, 2018 - 2032
            3.5 Global Nuclear Medicine market, by Region, 2018 - 2032
            3.6 Global Nuclear Medicine market, by Type, 2018 - 2032
            3.7 Global Nuclear Medicine market, by Application, 2018 - 2032

Chapter 4 Nuclear Medicine Segment by Types (Product Category) 
            4.1 Global Nuclear Medicine Revenue (USD Billion) and Growth Rate (%) Comparison by Types (2018-2023) 
            4.2 Global Nuclear Medicine Revenue Market Share (%) by Types in 2022
            4.3 Diagnostic
            4.4 Therapeutic

Chapter 5 Global Nuclear Medicine Segment by Application 
            5.1 Global Nuclear Medicine Revenue (USD Billion) Comparison by Application (2018-2032) 
            5.2 Oncology
            5.3 Cardiology
            5.4 Neurology
            5.5 Thyroid
            5.6 Others

Chapter 6 Global Nuclear Medicine Market by Regions (2018-2032) 
            6.1 Global Nuclear Medicine Market Size and Growth Rate (%) Comparison by Regions (2018-2032) 
            6.2 North America Nuclear Medicine Status and Prospect (2018-2032) 
            6.3 Europe Nuclear Medicine Status and Prospect (2018-2032) 
            6.4 Asia Pacific Nuclear Medicine Status and Prospect (2018-2032) 
            6.5 South America Nuclear Medicine Status and Prospect (2018-2032) 
            6.6 Middle East & Africa Nuclear Medicine Status and Prospect (2018-2032) 
            6.7 Global Nuclear Medicine Market Size (2018-2032) 
                        6.7.1 Global Nuclear Medicine Revenue Status and Outlook (2018-2032) 

Chapter 7 PESTEL Analysis
            7.1 Political Factors
            7.2 Economic Factors
            7.3 Social Factors
            7.4  Technological Factors
            7.5 Legal Factors
            7.6 Environment Factors

Chapter 8 Global Nuclear Medicine Market Competition by Manufacturers
            8.1 Global Nuclear Medicine Revenue and Share by Manufacturers (2018-2022) 

Chapter 9 Company (Top Players) Profiles and Key Data
            9.1 Mallinckrodt plc
                        9.1.1 Company Basic Information and Sales Area
                        9.1.2 Business Segment/ Overview
                        9.1.3 Investment in Research and Development
                        9.1.4 Nuclear Medicine Product Types Specification
                        9.1.5 Key Developments
                        9.1.6 Business Strategy
            9.2 General Electric Co. (healthcare division)
                        9.2.1  Company Basic Information and Sales Area
                        9.2.2 Business Segment/ Overview
                        9.2.3 Investment in Research and Development
                        9.2.4 Nuclear Medicine Product Types Specification
                        9.2.5 Business Strategy
            9.3 Medtronic, Inc.
                        9.3.1 Company Basic Information and Sales Area
                        9.3.2 Business Segment/ Overview
                        9.3.3 Nuclear Medicine Product Types Specification
                        9.3.4 Key Developments
                        9.3.5 Business Strategy
            9.4 Bayer AG
                        9.4.1 Company Basic Information and Sales Area. 
                        9.4.2 Business Segment/ Overview
                        9.4.3 Nuclear Medicine Product Types Specification
                        9.4.4 Business Strategy
            9.5 Cardinal Health, Inc.
                        9.5.1 Company Basic Information and Sales Area. 
                        9.5.2 Business Segment/ Overview
                        9.5.3 Nuclear Medicine Product Types Specification
                        9.5.4 Business Strategy
            9.6 Lantheus Medical Imaging, Inc.
                        9.6.1 Company Basic Information and Sales Area
                        9.6.2 Business Segment/ Overview
                        9.6.3 Nuclear Medicine Product Types Specification
                        9.6.4 Business Strategy
            9.7 IBA Group
                        9.7.1 Company Basic Information and Sales Area
                        9.7.2 Business Segment/ Overview
                        9.7.3 Investment in Research and Development
                        9.7.4 Nuclear Medicine Product Types Specification
                        9.7.5 Key Developments
                        9.7.6 Business Strategy
            9.8 Bracco Imaging
                        9.8.1 Company Basic Information and Sales Area. 
                        9.8.2 Business Segment/ Overview
                        9.8.3 Nuclear Medicine Product Types Specification
                        9.8.4 Business Strategy
            9.9 NTP Radioisotopes Soc, Ltd.
                        9.9.1 Company Basic Information and Sales Area
                        9.9.2 Business Segment/ Overview
                        9.9.3 Nuclear Medicine Product Types Specification
                        9.9.4 Business Strategy
             9.10 Siemens Healthcare
                        9.10.1 Company Basic Information and Sales Area
                        9.10.2 Business Segment/ Overview
                        9.10.3 Nuclear Medicine Product Types Specification
                        9.10.4 Business Strategy

Chapter 10 Global Nuclear Medicine Revenue by Regions (2018-2023) 
            10.1 Global Nuclear Medicine Revenue and Market Share (%) by Regions (2018-2023) 

Chapter 11 Global Nuclear Medicine Revenue by Types
            11.1 Global Nuclear Medicine Revenue and Market Share (%) by Types (2018-2023) 

Chapter 12 Global Nuclear Medicine Market Analysis by Application
            12.1 Global Nuclear Medicine Revenue (USD Billion) and Market Share (%) by Application (2018-2023) 
            12.2 Global Nuclear Medicine Revenue Growth Rate by Application (2018-2023) 

Chapter 13 North America Nuclear Medicine Market Development Status and Outlook
            13.1 North America Nuclear Medicine Market Size (2018-2023) 
                        13.1.1 North America Nuclear Medicine Market Size by Type (USD Billion) (2018-2023) 
            13.2 North America Nuclear Medicine Market Size (2018-2023) 
                        13.2.1 North America Nuclear Medicine Market Size by Application (USD Billion) (2018-2023) 
            13.3 U.S
                        13.3.1 U.S. Nuclear Medicine market, by Type, 2018 - 2032
                        13.3.2 U.S. Nuclear Medicine market, by Application, 2018 – 2032
            13.4 Canada
                        13.4.1 Canada Nuclear Medicine market, by Type, 2018 - 2032
                        13.4.2 Canada Nuclear Medicine market, by Application, 2018 – 2032
            13.5 Mexico
                        13.5.1 Mexico Nuclear Medicine market, by Type, 2018 - 2032
                        13.5.2 Mexico Nuclear Medicine market, by Application, 2018 – 2032

Chapter 14 Europe Nuclear Medicine Market Development Status and Outlook
            14.1 Europe Nuclear Medicine Market Size (2018-2023) 
                        14.1.1 Europe Nuclear Medicine Market Size by Type (USD Billion) (2018-2023) 
            14.2 Europe Nuclear Medicine Market Size (2018-2023) 
                        14.2.1 Europe Nuclear Medicine Market Size by Application (USD Billion) (2018-2023) 
            14.3 U.K.
                        14.3.1 U.K. Nuclear Medicine market, by Type, 2018 - 2032
                        14.3.2 U.K. Nuclear Medicine market, by Application, 2018 – 2032
            14.4 Germany
                        14.4.1 Germany Nuclear Medicine market, by Type, 2018 - 2032
                        14.4.2 Germany Nuclear Medicine market, by Application, 2018 – 2032
            14.5 France
                        14.5.1 France Nuclear Medicine market, by Type, 2018 – 2032
                        14.5.2 France Nuclear Medicine market, by Application, 2018 – 2032
            14.6 Italy
                        14.6.1 Italy Nuclear Medicine market, by Type, 2018 – 2032
                        14.6.2 Italy Nuclear Medicine market, by Application, 2018 – 2032
            14.7 Spain
                        14.7.1 Spain Nuclear Medicine market, by Type, 2018 – 2032
                        14.7.2 Spain Nuclear Medicine market, by Application, 2018 – 2032
            14.8 Rest of Europe
                        14.8.1 Rest of Europe Nuclear Medicine market, by Type, 2018 – 2032
                        14.8.2 Rest of Europe Nuclear Medicine market, by Application, 2018 – 2032

Chapter 15 Asia Pacific Nuclear Medicine Market Development Status and Outlook
            15.1 Asia Pacific Nuclear Medicine Market Size (2018-2023) 
                        15.1.1 Asia Pacific Nuclear Medicine Market Size by Type (USD Billion) (2018-2023) 
            15.2  Asia Pacific Nuclear Medicine Market Size (2018-2023) 
                        15.2.1 Asia Pacific Nuclear Medicine Market Size by Application (USD Billion) (2018-2023) 
            15.3 China
                        15.3.1 China Nuclear Medicine market, by Type, 2018 – 2032
                        15.3.2 China Nuclear Medicine market, by Application, 2018 – 2032
            15.4 Japan
                        15.4.1 Japan Nuclear Medicine market, by Type, 2018 – 2032
                        15.4.2 Japan Nuclear Medicine market, by Application, 2018 – 2032
            15.5 India
                        15.5.1 India Nuclear Medicine market, by Type, 2018 – 2032
                        15.5.2 India Nuclear Medicine market, by Application, 2018 – 2032
            15.6 Southeast Asia
                        15.6.1 Southeast Asia Nuclear Medicine market, by Type, 2018 – 2032
                        15.6.2 Southeast Asia Nuclear Medicine market, by Application, 2018 – 2032

Chapter 16 South America Nuclear Medicine Market Development Status and Outlook
            16.1 South America Nuclear Medicine Market Size (2018-2023) 
                        16.1.1 South America Nuclear Medicine Market Size by Type (USD Billion) (2018-2023) 
            16.2 South America Nuclear Medicine Market Size (2018-2023) 
                        16.2.1 South America Nuclear Medicine Market Size by Application (USD Billion) (2018-2023) 
            16.3 Brazil
                        16.3.1 Brazil Nuclear Medicine market, by Type, 2018 – 2032
                        16.3.2 Brazil Nuclear Medicine market, by Application, 2018 – 2032 
            16.4 Argentina
                        16.4.1 Argentina Nuclear Medicine market, by Type, 2018 – 2032
                        16.4.2 Argentina Nuclear Medicine market, by Application, 2018 – 2032 
            16.5 Colombia
                        16.5.1 Colombia Nuclear Medicine market, by Type, 2018 – 2032
                        16.5.2 Colombia Nuclear Medicine market, by Application, 2018 – 2032
            16.6 Rest of South America
                        16.6.1 Colombia Nuclear Medicine market, by Type, 2018 – 2032
                        16.6.2 Colombia Nuclear Medicine market, by Application, 2018 – 2032

Chapter 17 Middle East & Africa Nuclear Medicine Market Development Status and Outlook
            17.1 Middle East & Africa Nuclear Medicine Market Size (2018-2023) 
                        17.1.1 Middle East & Africa Nuclear Medicine Market Size by Type (USD Billion) (2018-2023) 
            17.2 Middle East & Africa Nuclear Medicine Market Size (2018-2023) 
                        17.2.1 Middle East & Africa Nuclear Medicine Market Size by Application (2018-2023) 
            17.3 UAE
                        17.3.1 UAE Nuclear Medicine market, by Type, 2018 – 2032
                        17.3.2 UAE Nuclear Medicine market, by Application, 2018 – 2032
            17.4 South Africa
                        17.4.1 South Africa Nuclear Medicine market, by Type, 2018 – 2032
                        17.4.2 South Africa Nuclear Medicine market, by Application, 2018 – 2032
            17.5 Egypt
                        17.5.1 Egypt Nuclear Medicine market, by Type, 2018 – 2032
                        17.5.2 Egypt Nuclear Medicine market, by Application, 2018 – 2032
            17.6 Rest of MEA
                        17.6.1 Rest of MEA Nuclear Medicine market, by Type, 2018 – 2032
                        17.6.2 Rest of MEA Nuclear Medicine market, by Application, 2018 – 2032

Chapter 18 Nuclear Medicine Manufacturing Cost Analysis
            18.1 Proportion of Manufacturing Cost Structure
                        18.1.1 Raw Materials
                        18.1.2 Labor Cost
                        18.1.3 USA Labor Cost Analysis
                        18.1.4 EU Labor Costs Analysis
                        18.1.5 China Labor Costs Analysis
                        18.1.6 Manufacturing Expenses

Chapter 19 Marketing Strategy Analysis, Distributors/ Traders
            19.1 Marketing Channel
                        19.1.1 Direct Marketing
                        19.1.2 Indirect Marketing
                        19.1.3 Marketing Channel Development Trend
            19.2 Market Positioning
                        19.2.1 Pricing Strategy

Chapter 20 Global Nuclear Medicine Market Forecast (2023-2032) 
            20.1 Global Nuclear Medicine Revenue Forecast (2023-2032) 
                        20.1.1 Global Nuclear Medicine Revenue (USD Billion) and Growth Rate (%) Forecast (2023-2032) 
            20.2 Global Nuclear Medicine Revenue (USD Billion) Forecast by Regions (2023-2032) 
                        20.2.1 North America Nuclear Medicine Revenue (USD Billion) Forecast (2023-2032) 
                        20.2.2 Europe Nuclear Medicine Revenue (USD Billion) Forecast (2023-2032) 
                        20.2.3 Asia Pacific Nuclear Medicine and Revenue (USD Billion) Forecast (2023-2032) 
                        20.2.4 South America Nuclear Medicine and Revenue (USD Billion) Forecast (2023-2032) 
                        20.2.5 Middle East & Africa Nuclear Medicine and Revenue (USD Billion) Forecast (2023-2032) 
            20.3 Global Nuclear Medicine Revenue Forecast by Type (2023-2032) 
            20.4 Global Nuclear Medicine Revenue (USD Billion) Forecast by Application (2023-2032) 

Chapter 21 North America Nuclear Medicine Market Development Status and Outlook
            21.1 North America Nuclear Medicine Market Size (2023-2032) 
                        21.1.1 North America Nuclear Medicine Market Size by Type (USD Billion) (2023-2032) 
            21.2 North America Nuclear Medicine Market Size (2023-2032) 
                        21.2.1 North America Nuclear Medicine Market Size by Application (USD Billion) (2023-2032) 
            21.3 U.S.
                        21.3.1 U.S. Nuclear Medicine market, by Type, 2023 – 2032
                        21.3.2 U.S. Nuclear Medicine market, by Application, 2023 – 2032
            21.4 Canada
                        21.4.1 Canada Nuclear Medicine market, by Type, 2023 – 2032
                        21.4.2 Canada Nuclear Medicine market, by Application, 2023 – 2032
            21.5 Mexico
                        21.5.1 Mexico Nuclear Medicine market, by Type, 2023 – 2032
                        21.5.2 Mexico Nuclear Medicine market, by Application, 2023 – 2032

Chapter 22 Europe Nuclear Medicine Market Development Status and Outlook
            22.1 Europe Nuclear Medicine Market Size (2023-2032) 
                        22.1.1 Europe Nuclear Medicine Market Size by Type (USD Billion) (2023-2032) 
            22.2 Europe Nuclear Medicine Market Size (2023-2032) 
                        22.2.1 Europe Nuclear Medicine Market Size by Application (USD Billion) (2023-2032) 
            22.3 U.K.
                        22.3.1 U.K. Nuclear Medicine market, by Type, 2023 – 2032
                        22.3.2 U.K. Nuclear Medicine market, by Application, 2023 – 2032
            22.4 Germany
                        22.4.1 Germany Nuclear Medicine market, by Type, 2023 – 2032
                        22.4.2 Germany Nuclear Medicine market, by Application, 2023 – 2032
            22.5 France
                        22.5.1 France Nuclear Medicine market, by Type, 2023 – 2032
                        22.5.2 France Nuclear Medicine market, by Application, 2023 – 2032
            22.6 Italy
                        22.6.1 France Nuclear Medicine market, by Type, 2023 – 2032
                        2.6.2 France Nuclear Medicine market, by Application, 2023 – 2032
            22.7 Spain
                        22.7.1 France Nuclear Medicine market, by Type, 2023 – 2032
                        22.7.2 France Nuclear Medicine market, by Application, 2023 – 2032
            22.8 Rest of Europe
                        22.8.1 France Nuclear Medicine market, by Type, 2023 – 2032
                        22.8.2 France Nuclear Medicine market, by Application, 2023 – 2032

Chapter 23 Asia Pacific Nuclear Medicine Market Development Status and Outlook
            23.1 Asia Pacific Nuclear Medicine Market Size (2023-2032) 
                        23.1.1 Asia Pacific Nuclear Medicine Market Size by Type (USD Billion) (2023-2032) 
            23.2 Asia Pacific Nuclear Medicine Market Size (2023-2032) 
                        23.2.1 Asia Pacific Nuclear Medicine Market Size by Application (USD Billion) (2023-2032) 
            23.3 China
                        23.3.1 China Nuclear Medicine market, by Type, 2023 – 2032
                        23.3.2 China Nuclear Medicine market, by Application, 2023 – 2032
            23.4 Japan
                        23.4.1 Japan Nuclear Medicine market, by Type, 2023 – 2032
                        23.4.2 Japan Nuclear Medicine market, by Application, 2023 – 2032
            23.5 India
                        23.5.1 India Nuclear Medicine market, by Type, 2023 – 2032
                        23.5.2 India Nuclear Medicine market, by Application, 2023 – 2032
            23.6 Southeast Asia
                        23.6.1 Southeast Asia Nuclear Medicine market, by Type, 2023 – 2032
                        23.6.2 Southeast Asia Nuclear Medicine market, by Application, 2023 – 2032

Chapter 24 South America Nuclear Medicine Market Development Status and Outlook
            24.1 South America Nuclear Medicine Market Size (2023-2032) 
                        24.1.1 South America Nuclear Medicine Market Size by Type (USD Billion) (2023-2032) 
            24.2 South America Nuclear Medicine Market Size (2023-2032) 
                        24.2.1 South America Nuclear Medicine Market Size by Application (USD Billion) (2023-2032) 
            24.3 Brazil
                        24.3.1 Brazil Nuclear Medicine market, by Type, 2023 – 2032
                        24.3.2 Brazil Nuclear Medicine market, by Application, 2023 – 2032 
            24.4 Argentina
                        24.4.1 Argentina Nuclear Medicine market, by Type, 2023 – 2032
                        24.4.2 Argentina Nuclear Medicine market, by Application, 2023 – 2032 
            24.5 Colombia
                        24.5.1 Colombia Nuclear Medicine market, by Type, 2023 – 2032
                        24.5.2 Colombia Nuclear Medicine market, by Application, 2023 – 2032
            24.6 Rest of South America
                        24.6.1 Colombia Nuclear Medicine market, by Type, 2023 – 2032
                        24.6.2 Colombia Nuclear Medicine market, by Application, 2023 – 2032

Chapter 25 Middle East & Africa Nuclear Medicine Market Development Status and Outlook
            25.1 Middle East & Africa Nuclear Medicine Market Size (2023-2032) 
                        25.1.1 Middle East & Africa Nuclear Medicine Market Size by Type (USD Billion) (2023-2032) 
            25.2 Middle East & Africa Nuclear Medicine Market Size (2023-2032) 
                        25.2.1 Middle East & Africa Nuclear Medicine Market Size by Application (USD Billion) (2023-2032) 
            25.3 UAE
                        25.3.1 UAE Nuclear Medicine market, by Type, 2023 – 2032
                        25.3.2 UAE Nuclear Medicine market, by Application, 2023 – 2032
            25.4 South Africa
                        25.4.1 South Africa Nuclear Medicine market, by Type, 2023 – 2032
                        25.4.2 South Africa Nuclear Medicine market, by Application, 2023 – 2032
            25.5 Egypt
                        25.5.1 Egypt Nuclear Medicine market, by Type, 2023 – 2032
                        25.5.2 Egypt Nuclear Medicine market, by Application, 2023 – 2032
            25.6 Rest of MEA
                        25.6.1 Rest of MEA Nuclear Medicine market, by Type, 2023 – 2032
                        25.6.2 Rest of MEA Nuclear Medicine market, by Application, 2023 – 2032

Chapter 26 Research Findings and Conclusion

No Methodology

No Available

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase